Revenue of $675 million; % reported growth; % organic growth; 6% non-COVID organic growth
GAAP EPS of $4.50; Adjusted EPS from continuing operations of $1.01
Updates full year 2023. | May 11, 2023
14.02.2023 - PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today reported financial results for the fourth quarter and full year ended January 1, 2023. Fourth Quarter 2022 The Company reported GAAP earnings per .
08.11.2022 - PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today reported financial results for the third quarter ended October 2, 2022. The Company reported GAAP earnings per share from continuing operations of .